In addition, Chen et al. demonstrated that selective inhibition of mTOR by compound OSI-027 attenuated doxorubicin-induced overexpression of P-gp in hepatocellular carcinoma cells (Chen et al., 2015). This evidence concerns the gene MTOR and hepatocellular carcinoma.